To evaluate whether lncRNA TUG1 influenced the resistance of oxaliplatin in CRC, the lncRNA TUG1 was silenced in CD133+/CD44+ cells isolated from HCT-116 and SW480 cells, and then, the cells were treated with different concentrations of oxaliplatin. This evidence concerns the gene CD44 and colorectal carcinoma.